nandrolone decanoate has been researched along with Neoplasm Metastasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allar, MJ; DeVita, SF; Richards, S; Sedransk, N; Spiers, AS | 1 |
| Alanko, A; Heinonen, E; Scheinin, T; Tolppanen, EM; Vihko, R | 1 |
1 trial(s) available for nandrolone decanoate and Neoplasm Metastasis
| Article | Year |
|---|---|
Beneficial effects of an anabolic steroid during cytotoxic chemotherapy for metastatic cancer.
Topics: Anabolic Agents; Antineoplastic Agents; Blood Cell Count; Clinical Trials as Topic; Drug Therapy, Combination; Erythropoiesis; Humans; Nandrolone; Nandrolone Decanoate; Neoplasm Metastasis; Neoplasms | 1981 |
1 other study(ies) available for nandrolone decanoate and Neoplasm Metastasis
| Article | Year |
|---|---|
Significance of estrogen and progesterone receptors, disease-free interval, and site of first metastasis on survival of breast cancer patients.
Topics: Breast Neoplasms; Female; Humans; Mastectomy; Nandrolone; Nandrolone Decanoate; Neoplasm Metastasis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Time Factors | 1985 |